Skip to main content
. 2020 Jun 19;13:2109–2118. doi: 10.2147/DMSO.S249025

Table 2.

Clinical and Laboratory Characteristics of Patients with KOA in the Present Study

Variables Total MetS vs nMetS
MetS-OA nMetS-OA P value
N, (%) 108 57 (52.78%) 51 (47.22%)
Age (years) 64.65 ± 8.32 64.11 ± 7.79 65.25 ± 8.92 0.476
Height (m) 1.61 ± 0.07 1.61 ± 0.06 1.60 ± 0.07 0.206
Weight (kg) 68.57 ± 10.12 72.79 ± 9.52 63.86 ± 8.66 <0.001
BMI (kg/m2) 26.52 ± 3.30 27.86 ± 2.99 25.02 ± 2.98 <0.001
WC (cm) 90.51 ±10.83 96.07 ± 9.25 84.30 ± 8.98 <0.001
Hypertension, n (%) 60 (55.56%) 42 (73.68%) 18 (35.29%) <0.001
FBG (mg/dl) 98.47 ± 23.48 105.31 ± 15.99 90.82 ± 27.94 <0.001
TG (mg/dl) 197.90 ± 130.21 262.26 ± 146.64 125.96 ± 46.91 <0.001
HDL-C (mg/dl) 51.76 ± 10.57 47.59 ± 11.04 56.43 ± 7.77 <0.001
CRP (mg/mL) 5.03 ± 2.76 5.99 ± 3.01 3.95 ± 1.97 <0.001
ESR (mm/h) 17.57 ± 15.32 21.00 ± 16.16 13.73 ± 13.46 0.013
Plasma leptin (ng/mL) 16.09 ± 9.90 20.49 ± 10.23 11.17 ± 6.75 <0.001
SF leptin (ng/mL) 11.73 ± 8.10 15.29 ± 8.72 7.76 ± 4.97 <0.001
Plasma adiponectin (ng/mL) 8.61 ± 2.00 9.99 ± 0.61 6.65 ± 1.61 <0.001
SF adiponectin (ng/mL) 2.11 ± 1.80 2.71 ± 1.89 1.24 ± 1.22 <0.001
Plasma resistin (ng/mL) 7.67 ± 4.61 9.63 ± 4.65 4.07 ± 0.75 <0.001
SF resistin (ng/mL) 2.96 ± 1.72 3.08 ± 1.89 2.73 ± 1.35 0.318
METS-IR 40.29 ± 6.98 44.57 ± 5.68 35.49 ± 4.87 <0.001

Note: Data are mean ± SD unless otherwise indicated.

Abbreviations: KOA, knee osteoarthritis; MetS-OA, osteoarthritis patients with metabolic syndrome; nMetS-OA, osteoarthritis patients without metabolic syndrome; BMI, body mass index; WC, waist circumference; FBG, fasting blood glucose; TG, triglycerides; HDL-C, high-density lipoprotein-cholesterol; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; SF, synovial fluid; METS-IR, metabolic score for insulin resistance.